BACKGROUND: Tumor-derived membranous vesicles (MV) isolated from sera of the patients with squamous cell carcinomas of the head and neck (HNSCC) induce apoptosis of activated CD8(+) T cells. We tested if MV molecular profile and activity correlate with disease progression. METHODS: CD8(+) Jurkat cells were incubated with MAGE 3/6(+), FasL(+), MHC class I(+) MV isolated from sera of 60 patients with HNSCC and 25 normal controls by exclusion chromatography and ultracentrifugation. Z-VAD-FITC binding to Jurkat was measured and correlated with clinical data. RESULTS: MV from patients' sera, but not from sera of normal controls, induced Jurkat cell apoptosis. Forty-five percent T cells+MV from patients with N(1)-N(3) disease were apoptotic versus 18% T cells+MV from patients with N(0) disease (p < .008). MV from patients with active disease (AD) expressed higher FasL levels than MV from patients with no evident disease (NED) or normal controls (p <or= .01). CONCLUSION: MAGE 3/6(+), FasL(+), and MHCI(+) MV in sera of patients induced T-cell apoptosis, which correlated with disease activity and the presence of lymph node metastases.
BACKGROUND:Tumor-derived membranous vesicles (MV) isolated from sera of the patients with squamous cell carcinomas of the head and neck (HNSCC) induce apoptosis of activated CD8(+) T cells. We tested if MV molecular profile and activity correlate with disease progression. METHODS:CD8(+) Jurkat cells were incubated with MAGE 3/6(+), FasL(+), MHC class I(+) MV isolated from sera of 60 patients with HNSCC and 25 normal controls by exclusion chromatography and ultracentrifugation. Z-VAD-FITC binding to Jurkat was measured and correlated with clinical data. RESULTS: MV from patients' sera, but not from sera of normal controls, induced Jurkat cell apoptosis. Forty-five percent T cells+MV from patients with N(1)-N(3) disease were apoptotic versus 18% T cells+MV from patients with N(0) disease (p < .008). MV from patients with active disease (AD) expressed higher FasL levels than MV from patients with no evident disease (NED) or normal controls (p <or= .01). CONCLUSION:MAGE 3/6(+), FasL(+), and MHCI(+) MV in sera of patients induced T-cell apoptosis, which correlated with disease activity and the presence of lymph node metastases.
Authors: F Andre; M Andersen; J Wolfers; A Lozier; G Raposo; V Serra; C Ruegg; C Flament; E Angevin; S Amigorena; L Zitvogel Journal: Adv Exp Med Biol Date: 2001 Impact factor: 2.622
Authors: B R Gastman; Y Atarshi; T E Reichert; T Saito; L Balkir; H Rabinowich; T L Whiteside Journal: Cancer Res Date: 1999-10-15 Impact factor: 12.701
Authors: Christoph Bergmann; Laura Strauss; Reinhard Zeidler; Stephan Lang; Theresa L Whiteside Journal: Cancer Immunol Immunother Date: 2007-01-31 Impact factor: 6.968
Authors: Douglas D Taylor; Ciçek Gerçel-Taylor; Karen S Lyons; Joanna Stanson; Theresa L Whiteside Journal: Clin Cancer Res Date: 2003-11-01 Impact factor: 12.531
Authors: Thomas K Hoffmann; Jan Müller-Berghaus; Robert L Ferris; Jonas T Johnson; Walter J Storkus; Theresa L Whiteside Journal: Clin Cancer Res Date: 2002-06 Impact factor: 12.531